Related Articles
RELB: A novel prognostic marker for glioblastoma as identified by population‑based analysis
RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma
High expression of GPNMB indicates an unfavorable prognosis in glioma: Combination of data from the GEO and CGGA databases and validation in tissue microarray
Stanniocalcin 1 is a prognostic biomarker in glioma
KIF18A interacts with PPP1CA to promote the malignant development of glioblastoma